Literature DB >> 9047389

Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.

D Lallemand1, G Spyrou, M Yaniv, C M Pfarr.   

Abstract

We have analysed the different Jun and Fos proteins as NIH3T3 fibroblasts pass from exponential growth to quiescence and during the first 24 h after their re-entry into the cell cycle following serum stimulation. We show that these proteins can be divided into 3 subgroups based on their pattern of expression. The first contains c-Jun, Jun-D and Fra-2 which are expressed at high level in cycling cells and are only mildly induced by serum. The second contains Jun-B, c-Fos, Fos-B and deltaFos-B whose levels are low in cycling cells but increase strongly and rapidly after stimulation by serum. The third group contains only Fra-1, which is absent from cycling cells and behaves as a delayed early response protein after serum stimulation. AP-1 binding activity is low both in cycling and quiescent fibroblasts but increases after stimulation by serum with kinetics matching the induction of the various Jun and Fos proteins. Antibody supershift analyses demonstrate that the composition of AP-1 binding activity reflects the relative abundance of each Jun and Fos protein. Furthermore, the state of post-translational modification varies continuously for all of the AP-1 proteins as growth conditions change. These data indicate that AP-1 activity during the G0-G1 transition is finely regulated and complex, involving changes both in protein expression and in posttranslational modification.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9047389     DOI: 10.1038/sj.onc.1200901

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription.

Authors:  I Bouallaga; S Massicard; M Yaniv; F Thierry
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

2.  An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.

Authors:  Peter M Burch; Ziqiang Yuan; Anne Loonen; Nicholas H Heintz
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  In vitro selection of Jun-associated proteins using mRNA display.

Authors:  Kenichi Horisawa; Seiji Tateyama; Masamichi Ishizaka; Nobutaka Matsumura; Hideaki Takashima; Etsuko Miyamoto-Sato; Nobuhide Doi; Hiroshi Yanagawa
Journal:  Nucleic Acids Res       Date:  2004-12-02       Impact factor: 16.971

4.  Epidermal growth factor receptor-induced activator protein 1 activity controls density-dependent growth inhibition in normal rat kidney fibroblasts.

Authors:  Jorrit J Hornberg; Henk Dekker; Peter H J Peters; Petra Langerak; Hans V Westerhoff; Jan Lankelma; Everardus J J van Zoelen
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

5.  Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Authors:  Jihane Basbous; Dany Chalbos; Robert Hipskind; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

6.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

7.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation.

Authors:  S Vuillaumier; I Dixmeras; H Messaï; C Lapouméroulie; D Lallemand; J Gekas; F F Chehab; C Perret; J Elion; E Denamur
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

8.  JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis.

Authors:  Rosa Farràs; Véronique Baldin; Sandra Gallach; Claire Acquaviva; Guillaume Bossis; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

9.  Stress-activated protein kinases are negatively regulated by cell density.

Authors:  D Lallemand; J Ham; S Garbay; L Bakiri; F Traincard; O Jeannequin; C M Pfarr; M Yaniv
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

10.  JunD protects against chronic kidney disease by regulating paracrine mitogens.

Authors:  Evangéline Pillebout; Jonathan B Weitzman; Martine Burtin; Carla Martino; Pierre Federici; Moshe Yaniv; Gérard Friedlander; Fabiola Terzi
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.